These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25960292)

  • 1. Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression.
    Li L; Lv B; Chen B; Guan M; Sun Y; Li H; Zhang B; Ding C; He S; Zeng Q
    Biochem Biophys Res Commun; 2015 Jul; 462(4):314-21. PubMed ID: 25960292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs.
    Wächter S; Wunderlich A; Greene BH; Roth S; Elxnat M; Fellinger SA; Verburg FA; Luster M; Bartsch DK; Di Fazio P
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
    Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
    Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
    Tang Y; Meng X; Yu X; Shang H; Chen S; Liao L; Dong J
    J Endocrinol Invest; 2020 Apr; 43(4):439-450. PubMed ID: 31612419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis.
    Riesco-Eizaguirre G; Wert-Lamas L; Perales-Patón J; Sastre-Perona A; Fernández LP; Santisteban P
    Cancer Res; 2015 Oct; 75(19):4119-30. PubMed ID: 26282166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
    Zhang M; Guo R; Xu H; Zhang M; Li B
    Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
    Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
    Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.
    Feng F; Wang H; Fu H; Wu S; Ye Z; Chen S; Li J
    Nucl Med Biol; 2011 Oct; 38(7):1053-8. PubMed ID: 21982575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-146b-3p Inhibits Proliferation and Migration and Modulates the Expression and Location of Sodium/Iodide Symporter in Dedifferentiated Thyroid Cancer by Potentially Targeting MUC20.
    Hou S; Xie X; Zhao J; Wu C; Li N; Meng Z; Cai C; Tan J
    Front Oncol; 2020; 10():566365. PubMed ID: 33489878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma.
    Kotlarek M; Kubiak A; Czetwertyńska M; Świerniak M; Gierlikowski W; Kolanowska M; Bakuła-Zalewska E; Jhiang SM; Jażdżewski K; Wójcicka A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miR-139-5p in radioiodine-resistant thyroid cancer.
    Pecce V; Sponziello M; Verrienti A; Grani G; Abballe L; Bini S; Annunziata S; Perotti G; Salvatori M; Zagaria L; Maggisano V; Russo D; Filetti S; Durante C
    J Endocrinol Invest; 2023 Oct; 46(10):2079-2093. PubMed ID: 36933170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor.
    Zarnegar R; Brunaud L; Kanauchi H; Wong M; Fung M; Ginzinger D; Duh QY; Clark OH
    Surgery; 2002 Dec; 132(6):984-90; discussion 990. PubMed ID: 12490845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
    Ortiz IMDP; Barros-Filho MC; Dos Reis MB; Beltrami CM; Marchi FA; Kuasne H; do Canto LM; de Mello JBH; Abildgaard C; Pinto CAL; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2018 Nov; 10(1):144. PubMed ID: 30454026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
    Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
    Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer.
    Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ
    Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma.
    Gierlikowski W; Broniarek K; Cheda Ł; Rogulski Z; Kotlarek-Łysakowska M
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
    Mishra A; Pal L; Mishra SK
    World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.